Jacob Korach

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Advanced Non Small Cell Lung Cancer

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Journal of gynecologic oncology

Future oncology (London, England)

Journal of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Shira Peleg Hasson, Shira Felder, Limor Helpman, Alexandra Taylor, Michal Shalamov, Sireen Abuakar, Smadar Bauer, Ronnie Shapira-Frommer, Inbal Greenhouse, Jacob Korach, Tatiana Rabin, Jeffrey Goldstein, Akram Saad
Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Antonio Gonzáles Martin, Ursula A Matulonis, Jacob Korach, Mansoor Raza Mirza, Kathleen M Moore, Xiaohua Wu, Whitney York, Divya Gupta, Stanislav Lechpammer, Bradley J Monk
Niraparib treatment for patients with BRCA -mutated ovarian cancer: review of clinical data and therapeutic context. Future oncology (London, England) 18 (23) (2022)
Jacob Korach, Nicoletta Colombo, Cesar Mendiola, Frédéric Selle, Ignacio Dolado, Margarita Donica, Amit M Oza
Outcome according to residual disease (surgeon's report vs pre-chemotherapy imaging) in patients with bevacizumab-treated ovarian cancer: Analysis of the ROSiA study. Journal of surgical oncology 120 (4) (2019)
Limor Helpman, Omri Zidan, Eitan Friedman, Sarit Kalfon, Tamar Perri, Gilad Ben-Baruch, Jacob Korach
Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates. Journal of gynecologic oncology 28 (5) (2017)